Nerelimomab

Names

[ CAS No. ]:
162774-06-3

[ Name ]:
Nerelimomab

Biological Activity

[Description]:

Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis[1][2].

[Related Catalog]:

Research Areas >> Infection

[In Vivo]

Nerelimomab (7.5 mg/kg，静脉输注) 在复发性菌血症的狒狒模型中保护动物免于死亡[1]。 Animal Model: Baboon model of recurrent bacteremia (Challenged with E.coli)[1] Dosage: 7.5 mg/kg Administration: i.v. infusion Result: Improved organ function and attenuated cytokine and plasminogen activator inhibitor release.

[References]

[1]. Schlag G, et al. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 1994 Jul;2(1):10-8; discussion 19-22.

[2]. Cohen J, et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996 Sep;24(9):1431-40.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.